NEW YORK, Jan. 7 /PRNewswire/ -- In conjunction with
Cell Genesys' (Nasdaq: CEGE) company presentation at the
JPMorgan H & Q Healthcare Conference, you are invited to listen to the
presentation that will be broadcast live over the Internet on
Tuesday, January 8, 2002, at 11:00 a.m. EST with Stephen A. Sherwin, M.D.,
chairman and chief executive officer of Cell Genesys.
What: Cell Genesys Company Update
JPMorgan H & Q Healthcare Conference
When: Tuesday, January 8, 2002, at 11:00 a.m. EST
Where: http://www.cellgenesys.com
How: Live over the Internet -- Simply log on to the web at the
address above
Cell Genesys, which is headquartered in Foster City, CA, is focused on the
development and commercialization of innovative therapeutic products for
cancer based on gene therapy technologies. The company is pursuing three
cancer product platforms-GVAX(R) cancer vaccines, oncolytic virus therapies
and in vivo cancer gene therapies. Clinical trials of GVAX(R) vaccines are
under way in prostate cancer, lung cancer, pancreatic cancer, leukemia and
myeloma. Clinical trials of oncolytic virus therapies include CG7060 and
CG7870 in prostate cancer. Preclinical stage programs include oncolytic virus
therapies and gene therapies for multiple types of cancer. Cell Genesys'
majority-owned subsidiary, Ceregene, is focused on gene therapies for
neurologic disorders. Cell Genesys also continues to hold approximately nine
million shares of common stock in its former subsidiary, Abgenix, an antibody
products company. For additional information, please visit the company's
website at http://www.cellgenesys.com.
If you are unable to participate during the live webcast, the call will be
archived on http://www.cellgenesys.com within 12 hours following the presentation and
will be available for two weeks. To access the replay, go to the Investor
Relations section of the site.
CONTACT: Jennifer Cook Williams of Cell Genesys, Inc., +1-650-425-4542.
SOURCE Cell Genesys, Inc.
 back to top
Related links:
http://www.cellgenesys.com
Company News On-Call:
http://www.prnewswire.com/comp/134113.html
CONTACT:
Jennifer Cook Williams of Cell Genesys, Inc.,
+1-650-425-4542
|
